USP22 and non-small cell lung carcinoma: Recently, overexpression of USP22 has been reported in several solid tumors including NSCLC and demonstrated to be associated with poor prognosis (Liu et al., 2010, 2011; Yang et al., 2011; Zhang et al., 2011).